Lena Thin

Lena Thin is a Clinical Senior Lecturer in the Department of Internal Medicine at the UWA Medical School, The University of Western Australia. She serves as a Consultant Gastroenterologist and the IBD Research Lead at Fiona Stanley Hospital, specializing in complex Inflammatory Bowel Disease (IBD) management and quality-of-care improvement.

Her academic qualifications include:

• Master of Clinical Research (MClinRes) from The University of Western Australia
• Medical Bachelor (MBBS) from The University of Western Australia

Dr. Thin's research centers on IBD pathophysiology and therapeutics, with emphasis on Crohn's disease and ulcerative colitis. Her work investigates biologic therapies (infliximab, ustekinumab), systemic complications including cardiovascular events and hormonal imbalances, and emerging treatments like GLP-1 receptor agonists for immune-mediated inflammatory conditions.

Analysis of her recent publications reveals a strong clinical research focus on IBD treatment safety, efficacy, and novel interventions. Her work predominantly utilizes meta-analyses, prospective cohort studies, and systematic reviews to address critical gaps in gastroenterology practice, particularly regarding biologic therapy persistence and systemic disease manifestations.

No specific scientific awards were documented in available sources. As the IBD Research Lead at Fiona Stanley Hospital, she oversees research initiatives and likely mentors junior clinicians, though formal student advisement details are unreported. Her leadership extends to multiple advisory boards focused on advancing IBD care standards.

Dr. Thin directs the IBD research unit at Fiona Stanley Hospital, which conducts clinical trials and observational studies to optimize patient outcomes. The unit collaborates internationally on therapeutic innovation and complication management in inflammatory bowel diseases.